Treatment of sickle cell pain.
Sickle cell disease affects 70,000 Americans who experience an average of 0.8 painful episodes each year. The pathophysiology of sickle cell pain is not completely understood. The disease is characterized by both acute and chronic pain syndromes. Patients with sickle cell pain often encounter barriers to receiving appropriate care, including lack of continuity of care and perceived opiate addiction. Studies describing pharmacotherapy for sickle cell pain have been primarily retrospective and uncontrolled. In analyzing the available literature regarding pathophysiology, assessment, and treatment of sickle cell pain, we found a need for increased practitioner education and intervention to improve the level of care provided to patients with this disease.
Marlowe
Karen F
KF
Pharmacy Practice Department, Auburn University, Alabama, USA.
Chicella
Michael F
MF
D000755:Anemia, Sickle Cell / Q000188:drug therapy* / Q000503:physiopathology / Q000523:psychology; D002986:Clinical Trials as Topic / Q000379:methods / Q000706:statistics & numerical data; D004359:Drug Therapy, Combination; D006801:Humans; D009294:Narcotics / Q000627:therapeutic use; D010146:Pain / Q000188:drug therapy* / Q000503:physiopathology / Q000523:psychology
D009294:Narcotics